In the future in both adult and pediatric HIV treatment and care, absolute CD4 count and CD4% are likely to continue to play a role in baseline care as well as in the setting of virologic failure as prognostic markers of disease progression while also guiding initiation of preventive treatment strategies for opportunistic infections. This evidence concerns the gene CD4 and Opportunistic infection.